Innovative immunotherapies and emerging treatments in type 1 diabetes management
Type 1 diabetes mellitus (T1D) is a chronic autoimmune disease characterized by the selective destruction of pancreatic insulin-producing beta cells, primarily mediated by CD4+ and CD8+ T cells. This review comprehensively examines the latest advances in immunotherapeutic approaches to T1D, categori...
Saved in:
Main Authors: | Malek Zarei, Mohammad Abbas Sheikholeslami, Masoud Mozaffari, Yassar Mortada |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Diabetes Epidemiology and Management |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666970624000519 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prolonged Honeymoon Phase in Adult-Onset Type 1 Diabetes Mellitus: A Case Study
by: Pranjali Shah
Published: (2024-04-01) -
Modeling dynamic changes in type 1 diabetes progression:Quantifying $\beta$-cell variation after the appearance ofislet-specific autoimmune responses
by: Patrick Nelson, et al.
Published: (2009-08-01) -
A pair of promising immune checkpoints PSGL-1 and VISTA from immunotolerance to immunotherapy
by: Manqing Peng, et al.
Published: (2024-12-01) -
Vitamin D and autoimmune diseases
by: Shir Azrielant, et al.
Published: (2017-01-01) -
D1S-Neuro Program: Frequency and Risk Factors for the Development of Diabetic Neuropathy in Pediatric Patients with Type 1 Diabetes Mellitus, a Single Center Study
by: Marco Piccoli, et al.
Published: (2024-12-01)